Early detection and prevention of genetic diseases through personalized genetic analysis
Personalized genetic analysis tools and services that enable early detection and prevention of genetic diseases, improving healthcare outcomes. This includes analyzing an individual's DNA to identify potential disease risks and recommending preventive measures. The market size for personalized genetic testing is estimated to reach $12 billion by 2027, with a compound annual growth rate of 8.7%.